Actualizado 19/01/2006 14:40
- Comunicado -

Roche & Trimeris Select Two Next Generation HIV Fusion Inhibitor Drug Candidates (y 2)

For more information, please contact: Laura Bertossi, Ketchum, Tel: +44-(0)207-611-3597, Email: laura.bertossi@ketchum.com. Libby Day, F. Hoffmann-La Roche Ltd., Tel: +41-616-87-02-36, Mob: +41-79-597-2054, Email: elisabeth.day@roche.com